8/26/15 16:35 | 8/25/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | NJ | D | | P | 70 | 14.00 | 33 | 5 | 10 | 54 | D | -41 | -7 | -44 | -51 | -48 | -41 | -15 | 4 | 5 | 0 | -7 | 27 | -53 | -78 |
8/21/15 07:01 | 8/20/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | NJ | D | | P | 75 | 15.00 | 33 | 5 | 11 | 49 | D | -36 | -11 | -36 | -50 | -46 | -43 | -21 | -17 | 1 | 12 | 6 | 9 | -48 | -71 |
8/19/15 07:33 | 8/18/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | NJ | D | | P | 80 | 15.95 | 33 | 5 | 13 | 44 | D | -22 | 3 | -28 | -41 | -35 | -34 | -27 | -5 | -4 | -11 | 2 | -8 | -55 | -73 |
8/14/15 08:02 | 8/13/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | NJ | D | | P | 83 | 16.59 | 33 | 5 | 15 | 39 | D | -19 | 9 | -19 | -36 | -32 | -32 | -29 | -23 | -1 | -18 | -6 | -10 | -56 | -73 |
12/10/13 16:15 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | MA | D | | M.d | 145 | 8.16 | 33 | 18 | 244 | 25 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 |
12/10/13 16:15 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | MA | D | | S.d | -434 | 24.50 | 33 | -18 | -41 | 25 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 |
11/30/09 16:19 | 11/30/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | MA | D | | P | 22 | 4.47 | 1 | 5 | | 1 | D | -21 | -24 | -59 | -23 | -11 | -10 | -12 | -5 | 0 | 0 | 2 | 14 | 40 | -7 |
11/30/09 13:53 | 11/30/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ellberger Larry | MA | D | | P | 45 | 4.50 | 1 | 10 | | 2 | D | -21 | -24 | -59 | -23 | -11 | -10 | -12 | -5 | -1 | 0 | 1 | 14 | 39 | -7 |